Diagnosis and multimodal therapy for extragastrointestinal stromal tumor of the prostate: A case report
- Authors:
- Zhenyu Ou
- Zhenzhen Cao
- Yao He
- Dihong Tang
View Affiliations
Affiliations: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Gynecologic Oncology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan 410013, P.R. China
- Published online on: June 14, 2013 https://doi.org/10.3892/etm.2013.1156
-
Pages:
378-380
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Extragastrointestinal stromal tumors (EGISTs), which are neoplasms outside the digestive tract, are predominantly observed in the greater omentum and retroperitoneum. The clinicopathological and molecular characteristics of EGISTs are similar to those of gastrointestinal stromal tumors (GISTs). EGISTs originating from the prostate are extremely rare. In this study, we report a case of a prostatic EGIST in a 39‑year‑old male, who presented with frequency, urgency, dysuria and a prostatic mass. A 10‑core transrectal ultrasound‑guided prostate biopsy was performed, and the histological and immunohistochemical results confirmed the diagnosis of EGIST. The patient received a radical prostatectomy, followed by targeted therapy with imatinib (400 mg, daily) for 1 year. Neither recurrence nor metastasis was detected at a 24‑month follow‑up.
View References
1.
|
Gold JS and Dematteo RP: Combined surgical
and molecular therapy: the gastrointestinal stromal tumor model.
Ann Surg. 244:176–184. 2006. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Reith JD, Goldblum JR, Lyles RH and Weiss
SW: Extragastrointestinal (soft tissue) stromal tumors: an analysis
of 48 cases with emphasis on histologic predictors of outcome. Mod
Pathol. 13:577–585. 2000. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Lee CH, Lin YH, Lin HY, Lee CM and Chu JS:
Gastrointestinal stromal tumor of the prostate: a case report and
literature review. Hum Pathol. 37:1361–1365. 2006. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Yinghao S, Bo Y and Xiaofeng G:
Extragastrointestinal stromal tumor possibly originating from the
prostate. Int J Urol. 14:869–871. 2007. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Van der Aa F, Sciot R, Blyweert W, et al:
Gastrointestinal stromal tumor of the prostate. Urology.
65:3882005.PubMed/NCBI
|
6.
|
Xue D, Chen H and Chen Y: Giant
extragastrointestinal stromal tumor in the transverse mesocolon
concomitant with gastric cancer in an elderly patient: Case report.
Oncol Lett. 5:627–630. 2013.PubMed/NCBI
|
7.
|
van Oosterom AT, Judson I, Verweij J, et
al European Organisation for Research and Treatment of Cancer Soft
Tissue and Bone Sarcoma Group: Safety and efficacy of imatinib
(STI571) in metastatic gastrointestinal stromal tumours: a phase I
study. Lancet. 358:1421–1423. 2001.PubMed/NCBI
|
8.
|
Demetri GD, von Mehren M, Blanke CD, et
al: Efficacy and safety of imatinib mesylate in advanced
gastrointestinal stromal tumors. N Engl J Med. 347:472–480. 2002.
View Article : Google Scholar : PubMed/NCBI
|
9.
|
Casali PG, Jost L, Reichardt P and
Schlemmer M: Gastrointestinal stromal tumors: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol.
19(Suppl 2): ii35–ii38. 2008.PubMed/NCBI
|
10.
|
Barros A, Linhares E, Valadão M, Gonçalves
R, Vilhena B, Gil C and Ramos C: Extragastrointestinal stromal
tumors (EGIST): a series of case reports. Hepatogastroenterology.
58:865–868. 2011.PubMed/NCBI
|